Medique Recalls 31 Different Over-the-Counter Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning; Sold Exclusively on Amazon.com (Recall Alert)

What was recalled

The U.S. Consumer Product Safety Commission (CPSC) has issued a recall notice concerning a significant batch of over-the-counter medications distributed under the Medique brand umbrella. This is not an isolated incident involving a single bottle or box; rather, it encompasses 31 distinct pharmaceutical products that were sold exclusively through Amazon.com. The scope of this recall is broad, affecting consumers who purchased these items on or after June 1, 2018. It is important to note that the affected inventory includes products that are still unexpired, meaning they may currently be sitting in medicine cabinets across the country, posing a silent risk until discovered.

The products involved span several well-known subsidiary brands associated with Medique, including Medi-First, Medi-First Plus, Dover, Otis Clapp, and Ecolab. These are not obscure supplements but common household remedies for pain relief, cold symptoms, and minor injuries. The recalled items include aspirin-containing products, acetaminophen-containing products, ibuprofen-containing products, lidocaine-containing products, diphenhydramine, loperamide, and naproxen products. Because these brands are often used interchangeably by shoppers looking for specific pain relievers or allergy medications, it is easy to overlook the brand name on the box if you are focused solely on the drug type.

To help you identify whether your product is part of this recall, please review the specific list below. The table details the exact product names, the active drug ingredients, the package type, and the number of packets contained in each size. If you have any of these items, they are subject to the recall:

• Medi-First Non-Aspirin Acetaminophen (acetaminophen 325 mg): Available in 2-tablet packets containing 50, 250, or 125 units.
• Medi-First Extra Strength Non-Aspirin Acetaminophen (acetaminophen 500 mg): Available in 2-tablet packets containing 50, 125, or 250 units.
• Medi-First Sinus Pain & Pressure (acetaminophen 500 mg): Available in 2-tablet packets containing 50, 125, or 250 units.
• Medique APAP (acetaminophen 325 mg): Available in 2-tablet packets containing 250 units.
• Medique Extra Strength APAP (acetaminophen 500 mg): Available in 2-tablet packets containing 50, 125, or 250 units.
• Medique Back Pain-Off (acetaminophen 250 mg): Available in 2-tablet packets containing 50, 100, or 250 units.
• Medique CCP Caffeine Fee (acetaminophen 325 mg): Available in 2-tablet packets containing 50 or 250 units.
• Medi-First Cold Relief (acetaminophen 325 mg): Available in 2-tablet packets containing 50, 125, or 250 units.
• Medique Cramp Tabs (acetaminophen 325 mg): Available in 2-tablet packets containing 50, 125, or 250 units.
• Medique Decorel Forte Plus (acetaminophen 325 mg): Available in 2-tablet packets containing 50 or 250 units.
• Medique Medicidin-D (acetaminophen 325 mg): Available in 2-tablet packets containing 50, 100, or 250 units.
• Dover Aminofen (acetaminophen 325 mg): Available in 2-tablet packets containing 250 units.
• Otis Clapp Back Quell (acetaminophen 200 mg): Available in 2-tablet packets containing 150 units.
• Otis Clapp Mygrex (acetaminophen 500 mg): Available in 2-tablet packets containing 150 units.
• Otis Clapp Valihist (acetaminophen 325 mg): Available in 2-tablet packets containing 150 units.
• Medi-First Pain Relief Extra Strength (acetaminophen 110 mg / aspirin 162 mg): Available in 2-tablet packets containing 50, 100, or 250 units.
• Medi-First Plus Pain Zappers (acetaminophen 250 mg / aspirin 250 mg): Available in 2-tablet packets containing 50 or 125 units.
• Medique Pain-Off (acetaminophen 250 mg / aspirin 250 mg): Available in 2-tablet packets containing 50, 100, or 250 units.
• Medi-First Aspirin (aspirin 325 mg): Available in 2-tablet packets containing 50, 125, or 250 units.
• Medi-First Plus Aspirin (aspirin 325 mg): Available in 2-tablet packets containing 50 or 125 units.
• Medique Aspirin (aspirin 325 mg): Available in 2-tablet packets containing 12, 100, or 250 units.
• Medique Diphen (diphenhydramine 25 mg): Available in 1-tablet packets containing 24 or 200 units.
• Medi-First Ibuprofen (ibuprofen 200 mg): Available in 2-tablet packets containing 4, 50, 125, or 250 units.
• Medique I-Prin (ibuprofen 200 mg): Available in 2-tablet packets containing 3, 100, or 250 units.
• Dover Addaprin (ibuprofen 200 mg): Available in 2-tablet packets containing 250 units.
• Medi-First Burn Cream with Lidocaine (lidocaine 0.9 grams): Available in packets containing 25 units.
• Medi-First Burn Spray (lidocaine HCl 2%): Sold in 2 oz bottles.
• Medi-First Blood Clotting Spray (lidocaine 4%): Sold in 3 oz bottles.
• Ecolab Burn Cream (lidocaine 0.9 grams): Available in packets containing 25 units.
• Medique Diamode (loperamide HCl 2 mg): Available in 1-tablet packets containing 6, 50, or 100 units.
• Medique Mediproxen (naproxen sodium 220 mg): Available in 1-tablet packets containing 50 or 100 units.

The hazard, explained

At first glance, the distinction between standard plastic packaging and child-resistant packaging might seem like a minor detail of retail display or manufacturing cost. However, in the context of household safety, this difference is the critical barrier between a harmless inconvenience and a medical emergency. The core issue with the recalled Medique products is that they contain regulated substances—specifically pain relievers, fever reducers, and antihistamines—that are legally required to be sealed in packaging designed to withstand the persistent but limited strength and dexterity of young children. When this specific type of packaging is missing or defective, the physical mechanism of protection fails entirely.

To understand why this matters, we have to look at how these medications work inside the body versus how they interact with a curious toddler. The recalled items include acetaminophen, aspirin, ibuprofen, diphenhydramine, and lidocaine. These are not inert substances; they are potent pharmacological agents. Acetaminophen and ibuprofen, for instance, are processed by the liver. In an adult dose, they safely reduce inflammation and pain. But a child’s body mass is significantly smaller, meaning their metabolic systems cannot process even a small fraction of an adult dose without becoming overwhelmed. If the packaging does not require a specific sequence of actions—such as pushing down while turning a cap—to open, a toddler can easily pop it open with simple pulling or twisting motions. Once the seal is broken, the pills are exposed and accessible.

The danger escalates quickly because these products often come in multi-count packets or large bottles. A child does not need to ingest the entire bottle to suffer poisoning; even a single tablet of certain concentrations can be toxic depending on the child's weight. For example, acetaminophen overdose is one of the most common causes of acute liver failure in children. The liver becomes overloaded by the drug metabolites, leading to cellular damage that may not show immediate symptoms but can become life-threatening within days. Similarly, diphenhydramine, an antihistamine found in some of the recalled items, affects the central nervous system. Ingestion can lead to severe drowsiness, confusion, rapid heartbeat, and in serious cases, seizures or coma.

Furthermore, the recall notes that these products were sold exclusively on Amazon.com, often in bulk quantities like 50-count or 250-count packets. This increases the risk profile because a household might store these large containers in easily accessible places like bathroom cabinets or kitchen counters where children can reach them. Without the mechanical resistance of proper child-resistant packaging, there is no physical deterrent to stop a determined child from accessing the medication. The hazard is not just that the medicine is dangerous; it is that the container offers no friction, no complexity, and no delay to prevent a child from getting to it during a moment of exploration.

This situation underscores why the Poison Prevention Packaging Act (PPPA) exists. It is not about convenience for adults, but about creating a physical barrier that aligns with human developmental stages. When that barrier is absent, as in this recall, the risk shifts from theoretical to immediate. The "hazard" is literally the ease of access combined with the high toxicity potential of the contents, creating a scenario where a simple act of curiosity can result in accidental poisoning.

Who is most at risk

The primary group facing immediate danger in this recall consists of young children, particularly those under the age of five. This vulnerability stems directly from a specific legal and safety requirement known as the Poison Prevention Packaging Act (PPPA). Under federal law, over-the-counter medications containing regulated substances—such as the acetaminophen, ibuprofen, aspirin, and diphenhydramine found in these Medique products—must be sold in packaging that is difficult for young children to open. The recalled Medi-First, Medi-First Plus, Medique, Dover, Otis Clapp, and Ecolab products failed to meet this standard because their packaging was not child-resistant. For a toddler or preschooler who explores the world by putting things in their mouth, this ordinary-looking blister pack or simple box offers no barrier. They can open it with ease, access the pills inside, and ingest them without any resistance from the container itself.

The risk is compounded by the nature of the medications involved. Many of the 31 recalled items contain acetaminophen (found in brands like Medi-First Non-Aspirin Acetaminophen and Medique Extra Strength APAP) or ibuprofen (such as Medi-First Ibuprofen). These are common pain relievers and fever reducers, but they are also highly toxic to small bodies if taken in the wrong amounts. A single adult dose can be a dangerous overdose for a small child. Because children often cannot distinguish between candy and medication due to similar colors or packaging designs, the lack of a secure, difficult-to-open seal makes accidental ingestion far more likely than it would be with properly regulated safety caps or sealed containers.

While young children are the most immediate physical risk due to their curiosity and size, other household members may also be vulnerable depending on how they store these products. Many consumers purchase these specific Medique brands in bulk quantities—packets of 50, 125, or even 250 units—often for home use, travel kits, or workplace first-aid stations. If these large boxes are stored in easily accessible locations like kitchen counters, bathroom cabinets without locks, or bedside tables, any family member who can open the outer carton gains access to a significant number of pills at once. Although no poisoning incidents have been reported as of the recall date, the potential for harm is severe because the packaging does not provide the "child-resistant" layer of protection that the law intends to offer.

Additionally, elderly individuals or those with limited dexterity might inadvertently leave these packages open after use, assuming they are safe. However, this group is less at risk of being the *primary* victims of accidental poisoning compared to young children, who lack the cognitive ability to understand the danger of swallowing medication. The core issue remains that for any household with a crawling or walking toddler, these unregulated packages transform everyday medicine into an accessible hazard. Parents and caregivers must assume that if a child can reach the box, they can open it.

How to tell if you have the recalled item

Because this recall covers such a wide variety of common household medicines, identifying whether your specific product is affected requires careful attention to detail. The Consumer Product Safety Commission (CPSC) has issued this alert for 31 distinct over-the-counter drugs sold exclusively through Amazon.com. This exclusivity is your first major clue: if you purchased these items from a local pharmacy, a big-box store, or any retailer other than Amazon, they are not part of this specific recall. The affected products were sold on or after June 1, 2018, so checking your purchase history on Amazon is a critical first step in narrowing down the list.

The second thing to check is the brand name. While the manufacturer is Medique, the products are distributed under several different well-known consumer brands. You need to look for packaging labeled as Medi-First, Medi-First Plus, Medique, Dover, Otis Clapp, or Ecolab. If your bottle or box does not display one of these six brand names, it is likely safe from this specific recall. However, if you do see one of these brands, you must look closer at the type of medication and its packaging format.

The recalled items include a mix of pain relievers (such as aspirin, acetaminophen, ibuprofen, naproxen), sleep aids or allergy medications (diphenhydramine), anti-diarrheal drugs (loperamide), and topical treatments like lidocaine creams and sprays. The packaging varies significantly depending on the product type. For most tablet packets, you will find the expiration date printed on either the top or side panels of the container carton in a [YEAR/MO] format. If you have a spray bottle, look for the expiration date on the front of the bottle. For spray cans, the date is located on the bottom. Verifying that the product is unexpired is also part of the identification process, as only unexpired items from this batch are included.

To be absolutely certain, you must cross-reference your item against the specific list of 31 recalled products. Look for exact matches in both the brand and the active ingredient strength. For example, Medi-First Non-Aspirin Acetaminophen (325 mg) in a 2-tablet packet with pack sizes of 50, 250, or 125 is included. Similarly, Medique Aspirin (325 mg) in pack sizes of 12, 100, or 250 is recalled. Even small differences in milligram strength or packet count can mean your product is not part of the recall. If you are unsure, do not guess; use the contact information provided by Medique to verify your specific lot number and packaging details.

What to do — step by step

Your refund, repair, or replacement options

What can happen if you ignore it

When a recall involves child-resistant packaging, the stakes are rarely about the product simply failing to work; they are about the potential for accidental ingestion by vulnerable household members. In this specific case involving Medique’s over-the-counter drugs, the failure to meet the Poison Prevention Packaging Act (PPPA) requirements creates a silent but significant hazard. If you continue to use these products without addressing the packaging issue, you are leaving a critical barrier against accidental poisoning completely removed. For households with young children who are curious, mobile, and prone to putting objects in their mouths, standard blister packs or non-compliant containers offer little more than an illusion of safety.

The primary risk here is acute poisoning. The recalled products include potent pain relievers such as acetaminophen, ibuprofen, aspirin, and naproxen, as well as antihistamines like diphenhydramine and anti-diarrheal medication containing loperamide. Each of these substances carries a narrow margin between a therapeutic dose and a toxic one for small bodies. A child who can easily open the non-child-resistant packaging described in this recall could consume multiple doses in seconds. Because the pills are often individually wrapped or contained in boxes that do not require specialized force to open, a toddler can bypass the safety features designed to keep them out of reach. The danger is compounded by the fact that these medications may look like candy or come in flavors that appeal to children, further lowering their guard against ingestion.

While the CPSC report notes that no incidents have been reported as of the recall date, the absence of reported cases does not mean the risk is absent. It means that, so far, luck has spared families from the consequences. However, ignoring the hazard relies entirely on chance. If a child were to ingest even a small number of these tablets, the consequences could range from mild symptoms like nausea and vomiting to severe, life-threatening conditions. Acetaminophen overdose, for instance, can cause irreversible liver damage that may not become apparent until days after ingestion. Ibuprofen and naproxen overdoses can lead to kidney failure, seizures, or metabolic acidosis. Aspirin toxicity can result in ringing in the ears, rapid breathing, and confusion, while diphenhydramine overdose can cause dangerous heart rhythms and extreme sedation.

Furthermore, the presence of lidocaine in the recalled burn creams and sprays introduces a different category of risk. Accidental ingestion of topical anesthetics by children can lead to numbness in the throat and mouth, which might interfere with breathing or swallowing reflexes, or result in systemic toxicity affecting the nervous system. By continuing to use these products, you are not just risking a minor upset; you are exposing your family to the possibility of emergency room visits, long-term health complications, or worse. The ease with which these packages open is the very mechanism that turns a standard household medicine into an immediate threat when left unsecured.

Staying safe: broader tips

While this specific recall highlights the critical importance of child-resistant packaging for over-the-counter medications, the underlying principle applies to nearly every hazardous item in your home. The Poison Prevention Packaging Act exists because young children are naturally curious explorers who often lack the cognitive ability to understand that a pill or powder is dangerous rather than sweet or interesting. Even when products meet federal safety standards, accidents can happen during moments of distraction. Therefore, relying solely on the packaging is not enough; you must create multiple layers of defense to keep your family safe from accidental ingestion or poisoning.

First and foremost, treat every medication—prescription, over-the-counter, or vitamin—as if it were poison until proven otherwise. Never refer to medicine as "candy" when talking to children, as this can encourage them to seek out bottles that look appealing. Store all medications in a locked cabinet or box, regardless of whether they come in child-resistant caps. Caps can be defeated by determined toddlers, and containers can be knocked over or opened if left on bathroom counters, kitchen islands, or nightstands where they are easily accessible. The safest place for any medication is out of sight and out of reach, ideally in a location that requires a key or a combination lock.

Equally important is the habit of resetting safety features immediately after use. It is common to leave a bottle open while measuring a dose or taking a pill, only to walk away before securing it again. This brief window is often all it takes for a child to grab the container. Make it a non-negotiable rule that no medication leaves its locked storage until you are ready to administer it, and ensure it returns there the second the dose is given. Additionally, be vigilant about "hidden" risks in your home. Many household cleaning products, detergents, and personal care items also contain substances that require child-resistant packaging. Ensure these items are stored just as securely as your medicines.

Finally, stay informed about product safety through official channels. Sign up for recall alerts from the U.S. Consumer Product Safety Commission (CPSC) or the Food and Drug Administration (FDA) on their websites. Regularly check your pantry and medicine cabinets to remove expired items, not only because they may lose efficacy but also because expired packaging can sometimes degrade, making it easier for children to open. By combining secure storage habits with ongoing awareness of product recalls and safety standards, you significantly reduce the risk of accidental harm in your household.